Brokers say these ASX 100 shares are buys right now

These high-quality shares could be just what your portfolio needs.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While the ASX 100 index may not be as well-known or widely followed as the benchmark ASX 200 index, what it lacks in attention it makes up for in quality.

Among the 100 companies included in the index are some of the biggest and brightest that Australia has to offer. But which ASX 100 shares are buys?

Two that could be worth considering according to analysts are listed below. Here's why they rate these ASX 100 shares as buys:

A young investor working on his ASX shares portfolio on his laptop.

Image source: Getty Images

Cochlear Limited (ASX: COH)

The first ASX 100 share that could be a buy is Cochlear.

It is a leading manufacturer and distributor of cochlear implantable devices for hearing impaired globally. It offers three main products: Cochlear implants, Baha bone conduction implants, and Cochlear Wireless Accessories.

Goldman Sachs believes Cochlear would be a top option for investors right now. Particularly given that trading conditions have improved materially now COVID headwinds are easing. It said:

Looking forward, we continue to express a general preference for the device/drug names over the service providers in the current environment, on the basis of: i) stronger pricing power; ii) more assured volume profiles; iii) more resilient/expanding market shares; and iv) stronger balance sheets.

We believe Cochlear screens well on these fundamental factors, and largely avoids the margin uncertainties prevalent across other verticals. We expect a sequential improvement in momentum through 2H23 (further elective volume improvement and new processor launch momentum, potentially tempered by some moderation in Acoustics). We forecast above guidance in FY23E (GSe: $306m vs. $290-305m) and believe shares will now be further supported by a newly announced multi-year buyback program (GSe: $75m/year).

Its analysts currently have a buy rating and $265.00 price target on its shares.

Seek Ltd (ASX: SEK)

Another ASX 100 share that could be a buy is Seek.

It operates an online employment classifieds platform across 12 countries. It has three main business segments: SEEK Employment, SEEK Learning, and SEEK International.

Morgans is positive on the company. Its analysts believe Seek will benefit from a number of tailwinds that lead to increased reliance on the company's products and services. It explains:

Of the classifieds players, we continue to see SEEK as the one with the most relative upside, a view that's based on the sustained listings growth we've seen over the period. The tailwinds that have driven elevated job ads (~210k currently, broadly flat on the robust pcp) and strong FY22 result appear to still remain in place, i.e. subdued migration, candidate scarcity and the drive for greater employee flexibility. With businesses looking to grow headcount in the coming months and job mobility at historically high levels according to the RBA, we see these favourable operating conditions driving increased reliance on SEEK's products.

Morgans has an add and $28.40 price target on Seek's shares.

Motley Fool contributor James Mickleboro has positions in Seek. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear and Seek. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Up 170% in a year: Are Codan shares a buy?

Investors have more than doubled their money in 12 months with this stock.

Read more »

A person leans over to whisper a secret to a colleague during a meeting.
Broker Notes

Bell Potter is tipping this ASX All Ords share as a buy with 15% upside

Let's see which share the broker is recommending to clients.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Fortescue shares: Buy, hold, or sell? Bell Potter gives its verdict

Let's see what the broker is saying about this mining giant.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Karoon Energy and Santos shares

A leading analyst delivers his verdict on Karoon Energy and Santos shares.

Read more »

An older woman gazes over the top of her glasses with a quizzical expression as if she is considering some information.
Broker Notes

Is this ASX 200 stock a buy, hold or sell after rising 15% year to date?

Can this high-performing stock keep rising?

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

Macquarie names 3 ASX shares to buy

Two miners and a packaging company are on the broker's list of stocks to watch.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Broker Notes

Are these ASX shares a buy, hold or sell according to Morgans after key updates?

Here's the latest guidance from Morgans.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »